Gilead Sciences made a $10 billion bet and lost.? They invested heavily into a drug that was denied release by the FDA.? Naturally, the stock was sold off sharply.? While the stock was sitting at highs of nearly $50.00, it is now a mere 10% of the level now.? But, just because the stock is beaten down as it is, does that mean it is a bad bet? ? [more
Gilead Sciences Inc (GILD) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 8,000 people. Gilead Sciences is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare
with concentration in Pharmaceuticals And Biosciences
. The company currently falls under 'Mid-Cap
' category with current market capitalization of 6.69 B. Gilead Sciences Inc conducts business under Healthcare
sector and is part of Pharmaceuticals And Biosciences
industry. This company has 1.56 B outstanding shares of which 15.82 M shares are currently shorted by private and institutional investors with about 1.65 trading days to cover.
GILEAD SCIENCES currently holds about 616.93 M in cash with 74.41 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.31.
Check Gilead Sciences Probability Of Bankruptcy